Jan 4 (Reuters) - Moderna Inc (MRNA.O) said on Monday it would produce at least 600 million doses of its COVID-19 vaccine in 2021, up by 100 million doses from its previous forecast, as the United States continues to roll-out the vaccine.
The company was working to invest and hire in order to deliver up to 1 billion doses this year, the higher end of its production forecast, it said.
Moderna said it has so far supplied about 18 million doses to U.S. government as part of a deal for 200 million doses. It has also signed a deal with the Canadian government for 40 million doses.
Our Standards: The Thomson Reuters Trust Principles.